Atria Wealth Solutions, Inc. Gt Biopharma, Inc. Transaction History

Atria Wealth Solutions, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.22 - $0.28 $2,200 - $2,800	10,000 Added 11.27%	98,720 $25,000
Q3 2023 Nov 08, 2023	BUY	$0.24 - $0.35 $4,800 - $7,000	20,000 Added 29.1%	88,720 $21,000
Q2 2022 Aug 15, 2022	BUY	$1.64 - $3.11 $96,300 - $182,619	58,720 Added 587.2%	68,720 $205,000
Q1 2022 May 16, 2022	BUY	$2.6 - $3.3 $26,000 - $33,000	10,000 New	10,000 $29,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $81.7M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.